Effects of repeated quetiapine treatment on conditioned avoidance responding in rats

Jun Gao, Min Feng, Natashia Swalve, Collin Davis, Nan Sui, Ming Li

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The present study characterized the behavioral mechanisms of avoidance-disruptive effect of quetiapine in the conditioned avoidance response test under two behavioral testing (2 warning signals vs. 1 warning signal) and two drug administration conditions (subcutaneous vs. intravenous). In Experiments 1 and 2, well-trained adult male Sprague-Dawley rats were tested under the subcutaneous (s.c.) quetiapine treatment (5.0, 15.0, 25.0, 50.0 mg/kg) for 7 days in a novel procedure consisting of two conditioned stimuli (CS) (white noise serving as CS1 and pure tone as CS2). Only the highest dose (50.0 mg/kg) produced a persistent suppression of the avoidance response without impairing the escape response. The magnitude of suppression of the CS1 avoidance was similar to that of CS2 avoidance. No significant group difference was found in the quetiapine (15.0 mg/kg, s.c.) challenge test, indicating a lack of a long-term quetiapine effect. In Experiment 3, well-trained rats were tested under the intravenous (i.v.) quetiapine treatment (3.0, 9.0, 15.0 mg/kg) for 5 days and challenged with quetiapine (6.0 mg/kg, i.v. followed by 9.0 mg/kg, s.c.). Only the white noise was used as the CS. Similar to what was being observed in Experiments 1 and 2, intravenously administered quetiapine dose-dependently suppressed avoidance responding during the drug test days, but did not alter drug sensitivity in the challenge days. Thus, quetiapine does not appear to show a preferential inhibition of the avoidance response to a less salient stimulus; and prior quetiapine treatment (s.c. and i.v.) does not cause a sensitization or tolerance to quetiapine.

Original languageEnglish (US)
Pages (from-to)154-161
Number of pages8
JournalEuropean Journal of Pharmacology
Volume769
DOIs
StatePublished - Dec 15 2015

Fingerprint

Quetiapine Fumarate
Pharmaceutical Preparations
Sprague Dawley Rats

Keywords

  • CS1 and CS2
  • Conditioned avoidance response
  • Quetiapine
  • Sensitization
  • Tolerance

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of repeated quetiapine treatment on conditioned avoidance responding in rats. / Gao, Jun; Feng, Min; Swalve, Natashia; Davis, Collin; Sui, Nan; Li, Ming.

In: European Journal of Pharmacology, Vol. 769, 15.12.2015, p. 154-161.

Research output: Contribution to journalArticle

Gao, Jun ; Feng, Min ; Swalve, Natashia ; Davis, Collin ; Sui, Nan ; Li, Ming. / Effects of repeated quetiapine treatment on conditioned avoidance responding in rats. In: European Journal of Pharmacology. 2015 ; Vol. 769. pp. 154-161.
@article{164aa7bdafa74aecb9f8c7c0f2c41619,
title = "Effects of repeated quetiapine treatment on conditioned avoidance responding in rats",
abstract = "The present study characterized the behavioral mechanisms of avoidance-disruptive effect of quetiapine in the conditioned avoidance response test under two behavioral testing (2 warning signals vs. 1 warning signal) and two drug administration conditions (subcutaneous vs. intravenous). In Experiments 1 and 2, well-trained adult male Sprague-Dawley rats were tested under the subcutaneous (s.c.) quetiapine treatment (5.0, 15.0, 25.0, 50.0 mg/kg) for 7 days in a novel procedure consisting of two conditioned stimuli (CS) (white noise serving as CS1 and pure tone as CS2). Only the highest dose (50.0 mg/kg) produced a persistent suppression of the avoidance response without impairing the escape response. The magnitude of suppression of the CS1 avoidance was similar to that of CS2 avoidance. No significant group difference was found in the quetiapine (15.0 mg/kg, s.c.) challenge test, indicating a lack of a long-term quetiapine effect. In Experiment 3, well-trained rats were tested under the intravenous (i.v.) quetiapine treatment (3.0, 9.0, 15.0 mg/kg) for 5 days and challenged with quetiapine (6.0 mg/kg, i.v. followed by 9.0 mg/kg, s.c.). Only the white noise was used as the CS. Similar to what was being observed in Experiments 1 and 2, intravenously administered quetiapine dose-dependently suppressed avoidance responding during the drug test days, but did not alter drug sensitivity in the challenge days. Thus, quetiapine does not appear to show a preferential inhibition of the avoidance response to a less salient stimulus; and prior quetiapine treatment (s.c. and i.v.) does not cause a sensitization or tolerance to quetiapine.",
keywords = "CS1 and CS2, Conditioned avoidance response, Quetiapine, Sensitization, Tolerance",
author = "Jun Gao and Min Feng and Natashia Swalve and Collin Davis and Nan Sui and Ming Li",
year = "2015",
month = "12",
day = "15",
doi = "10.1016/j.ejphar.2015.11.011",
language = "English (US)",
volume = "769",
pages = "154--161",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",

}

TY - JOUR

T1 - Effects of repeated quetiapine treatment on conditioned avoidance responding in rats

AU - Gao, Jun

AU - Feng, Min

AU - Swalve, Natashia

AU - Davis, Collin

AU - Sui, Nan

AU - Li, Ming

PY - 2015/12/15

Y1 - 2015/12/15

N2 - The present study characterized the behavioral mechanisms of avoidance-disruptive effect of quetiapine in the conditioned avoidance response test under two behavioral testing (2 warning signals vs. 1 warning signal) and two drug administration conditions (subcutaneous vs. intravenous). In Experiments 1 and 2, well-trained adult male Sprague-Dawley rats were tested under the subcutaneous (s.c.) quetiapine treatment (5.0, 15.0, 25.0, 50.0 mg/kg) for 7 days in a novel procedure consisting of two conditioned stimuli (CS) (white noise serving as CS1 and pure tone as CS2). Only the highest dose (50.0 mg/kg) produced a persistent suppression of the avoidance response without impairing the escape response. The magnitude of suppression of the CS1 avoidance was similar to that of CS2 avoidance. No significant group difference was found in the quetiapine (15.0 mg/kg, s.c.) challenge test, indicating a lack of a long-term quetiapine effect. In Experiment 3, well-trained rats were tested under the intravenous (i.v.) quetiapine treatment (3.0, 9.0, 15.0 mg/kg) for 5 days and challenged with quetiapine (6.0 mg/kg, i.v. followed by 9.0 mg/kg, s.c.). Only the white noise was used as the CS. Similar to what was being observed in Experiments 1 and 2, intravenously administered quetiapine dose-dependently suppressed avoidance responding during the drug test days, but did not alter drug sensitivity in the challenge days. Thus, quetiapine does not appear to show a preferential inhibition of the avoidance response to a less salient stimulus; and prior quetiapine treatment (s.c. and i.v.) does not cause a sensitization or tolerance to quetiapine.

AB - The present study characterized the behavioral mechanisms of avoidance-disruptive effect of quetiapine in the conditioned avoidance response test under two behavioral testing (2 warning signals vs. 1 warning signal) and two drug administration conditions (subcutaneous vs. intravenous). In Experiments 1 and 2, well-trained adult male Sprague-Dawley rats were tested under the subcutaneous (s.c.) quetiapine treatment (5.0, 15.0, 25.0, 50.0 mg/kg) for 7 days in a novel procedure consisting of two conditioned stimuli (CS) (white noise serving as CS1 and pure tone as CS2). Only the highest dose (50.0 mg/kg) produced a persistent suppression of the avoidance response without impairing the escape response. The magnitude of suppression of the CS1 avoidance was similar to that of CS2 avoidance. No significant group difference was found in the quetiapine (15.0 mg/kg, s.c.) challenge test, indicating a lack of a long-term quetiapine effect. In Experiment 3, well-trained rats were tested under the intravenous (i.v.) quetiapine treatment (3.0, 9.0, 15.0 mg/kg) for 5 days and challenged with quetiapine (6.0 mg/kg, i.v. followed by 9.0 mg/kg, s.c.). Only the white noise was used as the CS. Similar to what was being observed in Experiments 1 and 2, intravenously administered quetiapine dose-dependently suppressed avoidance responding during the drug test days, but did not alter drug sensitivity in the challenge days. Thus, quetiapine does not appear to show a preferential inhibition of the avoidance response to a less salient stimulus; and prior quetiapine treatment (s.c. and i.v.) does not cause a sensitization or tolerance to quetiapine.

KW - CS1 and CS2

KW - Conditioned avoidance response

KW - Quetiapine

KW - Sensitization

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=84949094843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949094843&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2015.11.011

DO - 10.1016/j.ejphar.2015.11.011

M3 - Article

C2 - 26586334

AN - SCOPUS:84949094843

VL - 769

SP - 154

EP - 161

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

ER -